As a service to local statisticians, WSS News provides notification of employment opportunities and description of those seeking employment here in the Washington, DC, area. Readers are encouraged to take advantage of this feature of the newsletter. The deadline for inserting notices is five (5) weeks before the publication date. Those interested should email or call Anne Peterson, at email@example.com or (703) 504-9483.
The Biometric Research Branch of the National Cancer Institute is seeking candidates with a Ph.D. in statistics or biostatistics. Statisticians in the group have the following main functions: conduct research in biostatistics, bioinformatics, and computational biology on topics ranging from methodology to facilitate understanding at the molecular level of the pathogenesis of cancer to methodology to enhance the conduct of clinical trials of new therapeutic and diagnostic approaches; provide consulting and statistical leadership for the national and international research programs of the NCI in clinical trials to evaluate therapy, developmental therapeutics, developmental diagnostics, and diagnostic imaging.
The Biometric Research Branch (BRB) is the statistical and biomathematical component of the Division of Cancer Treatment and Diagnosis of the National Cancer Institute (of the National Institutes of Health). Its members provide consulting and statistical leadership for the national and international research programs of the division in developmental therapeutics, developmental diagnostics, diagnostic imaging, and clinical trials to evaluate therapy. The members of the Branch (BRB) conduct research in biostatistics, bioinformatics and computational biology on topics ranging from methodology to facilitate understanding at the molecular level of the pathogenesis of cancer to methodology to enhance the conduct of clinical trials of new therapeutic and diagnostic approaches. In particular, the BRB staff collaborates in the design and implementation of analytic tools to predict clinical efficacy, or action against a molecular target, for potential anti-cancer agents, from the NCI in-vitro and in-vivo tumor cell line screens. The BRB collaborate in research to elucidate the inter-related roles of agent biochemical mechanism and tumor molecular characteristics. The BRB conduct independent and collaborative research on the effects of new cancer treatments, and on improved statistical methodology for the evaluation of new treatments and they develop mathematical models for the design of treatment regimens for evaluation in clinical trials. The BRB also develops statistical and computational methods and bioinformatic systems for the analysis of genome and gene expression data.
BRB offices are located in the suburbs of Washington D.C. on the NCI Rockville, MD headquarters, 15 minutes from the NCI/NIH Bethesda campus. Candidates must be U.S. citizens. Experience in the statistical methodology of clinical trials design and analysis, in particular, the role of biomarkers in diagnosis and therapeutic decision making is advantageous. This is a pre-vacancy announcement to gauge interest. Individuals should send their resume and a statement of interest to Dr. Richard Simon, Chief BRB, at firstname.lastname@example.org. Additional information is at http://brb.nci.nih.gov.
DHHS, NIH and NCI are Equal Opportunity Employers.